diclofenac has been researched along with Cognition Disorders in 2 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mann, E | 1 |
| Haastert, B | 1 |
| Böhmdorfer, B | 1 |
| Frühwald, T | 1 |
| Iglseder, B | 1 |
| Roller-Wirnsberger, R | 1 |
| Meyer, G | 1 |
| Nawata, Y | 1 |
| Yamaguchi, T | 1 |
| Yamamoto, T | 1 |
2 other studies available for diclofenac and Cognition Disorders
| Article | Year |
|---|---|
Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study.
Topics: Adult; Age Distribution; Aged; Austria; Cognition Disorders; Comorbidity; Cross-Sectional Studies; D | 2013 |
[JSNP Excellent Presentation Award for AsCNP 2011: improvement of cognitive impairments on withdrawal after repeated methamphetamine by administration of a cannabinoid CB1 receptor antagonist and a COX inhibitor].
Topics: Animals; Awards and Prizes; Cognition Disorders; Cyclooxygenase Inhibitors; Diclofenac; Male; Metham | 2012 |